Murad Melhem

Murad Melhem is the head of Clinical Pharmacology, Modeling and Simulation (Oncology) at GSK overseeing the clinical pharmacology strategies and execution for the whole oncology portfolio.

Trained as Pharmacist, and a quantitative scientist at heart, Murad’s career in drug development has spanned therapeutic areas including cardio-metabolic, endocrine, neuro- and neurodegenerative diseases, immunology and oncology, as well as modalities including small molecules, mAbs, peptides and peptide-mimetics and T-cell engagers. Murad is considered an expert on dose optimization and model-informed drug development.

Murad has contributed to many successful programs across therapeutic areas and contributed to quite a few drug approvals.